Seon-Wook Hwang

Director Ejecutivo en NOVMETAPHARMA CO., LTD. .

Fortuna: 17 M $ al 31/07/2023

64 años

Health Technology

Consumer Services

Perfil

Seon-Wook Hwang is currently the President, Co-Chief Executive Officer & Director at NovMetaPharma Co., Ltd.
He is also the Chief Executive Officer at PNC Holdings Co. Ltd.
and NovMetaHealth Co. Ltd.
Mr. Hwang completed his undergraduate and graduate degrees at Chung-Ang University.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
NOVMETAPHARMA CO., LTD. 9.36%	30/06/2023	1 038 030 ( 9.36% )	17 M $	31/07/2023

Cargos activos de Seon-Wook Hwang

Empresas	Cargo	Inicio
NOVMETAPHARMA CO., LTD.	Director Ejecutivo	04/11/2010
NovMetaHealth Co. Ltd. NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.	Director Ejecutivo	01/03/2016
PNC Holdings Co. Ltd.	Director Ejecutivo	01/09/2015

Todos los cargos activos de Seon-Wook Hwang

Formación de Seon-Wook Hwang.

Chung-Ang University

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Seon-Wook Hwang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NOVMETAPHARMA CO., LTD.	Health Technology

Empresas privadas	2
NovMetaHealth Co. Ltd. NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.	Health Technology
PNC Holdings Co. Ltd.